Skip to Content

CAP 150 (Capecitabine 150 mg)

Pill with imprint CAP 150 is Pink, Capsule-shape and has been identified as Capecitabine 150 mg. It is supplied by Shilpa Medicare Limited.

Capecitabine is used in the treatment of breast cancer, metastatic; colorectal cancer; breast cancer; anal cancer and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CAP 150

Capecitabine

Imprint
CAP 150
Strength
150 mg
Color
Pink
Size
11.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antimetabolites
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Shilpa Medicare Limited
National Drug Code (NDC)
63759-3000
Inactive Ingredients
lactose anhydrous, croscarmellose sodium, hypromelloses, microcrystalline cellulose, magnesium stearate, water, titanium dioxide, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.